Localisation of Neuregulin 1-β3 to different sub-nuclear structures alters gene expression

Experimental Cell Research

Volumn 317, Issue 4, 2011, Pages 423-432

  Wang, Ming ^a   Trim, Carol M ^a   Gullick, William J ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Growth factor; Neuregulin; Nucleoli; Spliceosome

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GEFITINIB; GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN 70; LYSINE; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; NEUREGULIN 1 ALPHA; NEUREGULIN 1 BETA3; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN COS7; CELL TRANSPORT; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SPLICEOSOME;

ANIMALIA;

EID: 78651422098     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.11.009     Document Type: Article

References (24)

1. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2001, 2:127-137.
2. Stein R.A., Staros J.V. Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis. BMC Evol. Biol. 2006, 6:79.
3. Hayes N.V., Newsam R.J., Baines A.J., Gullick W.J. Characterization of the cell membrane-associated products of the Neuregulin 4 gene. Oncogene 2008, 27:715-720.
4. Johnson H.M., Subramaniam P.S., Olsnes S., Jans D.A. Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 2004, 26:993-1004.
5. Linggi B., Carpenter G. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol. 2006, 16:649-656.
6. Marshall C., Blackburn E., Clark M., Humphreys S., Gullick W.J. Neuregulins 1-4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast. Breast Cancer Res. Treat. 2006, 96:163-168.
7. Golding M., Ruhrberg C., Sandle J., Gullick W.J. Mapping nucleolar and spliceosome localization sequences of neuregulin1-beta3. Exp. Cell Res. 2004, 299:110-118.
8. Breuleux M., Schoumacher F., Rehn D., Kung W., Mueller H., Eppenberger U. Heregulins implicated in cellular functions other than receptor activation. Mol. Cancer Res. 2006, 4:27-37.
9. Srinivasan R., Benton E., McCormick F., Thomas H., Gullick W.J. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer. Clin. Cancer Res. 1999, 5:2877-2883.
10. Patterson G.H., Lippincott-Schwartz J. A photoactivatable GFP for selective photolabeling of proteins and cells. Science 2002, 297:1873-1877.
11. Offterdinger M., Schofer C., Weipoltshammer K., Grunt T.W. c-erbB-3: a nuclear protein in mammary epithelial cells. J. Cell Biol. 2002, 157:929-939.
12. Carpenter G., Liao H.J. Trafficking of receptor tyrosine kinases to the nucleus. Exp. Cell Res. 2009, 315:1556-1566.
13. Ferrer-Soler L., Vazquez-Martin A., Brunet J., Menendez J.A., De Llorens R., Colomer R. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). Int. J. Mol. Med. 2007, 20:3-10.
14. Brehmer D., Greff Z., Godl K., Blencke S., Kurtenbach A., Weber M., Muller S., Klebl B., Cotten M., Keri G., Wissing J., Daub H. Cellular targets of gefitinib. Cancer Res. 2005, 65:379-382.
15. Fabian M.A., Biggs W.H., Treiber D.K., Atteridge C.E., Azimioara M.D., Benedetti M.G., Carter T.A., Ciceri P., Edeen P.T., Floyd M., Ford J.M., Galvin M., Gerlach J.L., Grotzfeld R.M., Herrgard S., Insko D.E., Insko M.A., Lai A.G., Lelias J.M., Mehta S.A., Milanov Z.V., Velasco A.M., Wodicka L.M., Patel H.K., Zarrinkar P.P., Lockhart D.J. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotechnol. 2005, 23:329-336.
16. Carteron C., Ferrer-Montiel A., Cabedo H. Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J. Cell Sci. 2006, 119:898-909.
17. Hayes N.V., Gullick W.J. The neuregulin family of genes and their multiple splice variants in breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:205-214.
18. Bennett-Lovsey R.M., Herbert A.D., Sternberg M.J., Kelley L.A. Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins 2008, 70:611-625.
19. Steinthorsdottir V., Stefansson H., Ghosh S., Birgisdottir B., Bjornsdottir S., Fasquel A.C., Olafsson O., Stefansson K., Gulcher J.R. Multiple novel transcription initiation sites for NRG1. Gene 2004, 342:97-105.
20. Bagheri-Yarmand R., Vadlamudi R.K., Wang R.A., Mendelsohn J., Kumar R. Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis. J. Biol. Chem. 2000, 275:39451-39457.
21. Mazumdar A., Adam L., Boyd D., Kumar R. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res. 2001, 61:400-405.
22. Li W., Park J.W., Nuijens A., Sliwkowski M.X., Keller G.A. Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene 1996, 12:2473-2477.
23. Mandal M., Li F., Kumar R. Heregulin up-regulates heat shock protein-70 expression in breast cancer cells. Anticancer Res. 2002, 22:1965-1969.
24. Khaleque M.A., Bharti A., Sawyer D., Gong J., Benjamin I.J., Stevenson M.A., Calderwood S.K. Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene 2005, 24:6564-6573.